EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Aspire Biopharma (NASDAQ: ASBP) completes $30M cash acquisition of Dura Driver Control Systems, adding $200M+ in annual revenue.
Read original at benzingaStocks · News reference
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at $3.0
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 29, 2026, 9:06 PM
- Checked
- Jul 29, 2026, 9:05 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
EXCLUSIVE: Aspire Biopharma Completes Dura Driver Control Systems Acquisition, Automotive Supplier with Over $200M 2025 Revenue; Expects Improved Path To Profitability
Read original at benzingaWhy JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares rise 3.6% in pre-market trading.
Read original at benzingaWhy Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Cadeler A/S (NYSE: CDLR) surged in pre-market trading after reporting strong financial results for the first half of 2026. Revenue and profit increased significantly, and full-year guidance was maintained. Other stocks also moved in pre-market trading.
Read original at benzingaBiodexa Says 87 Of Planned 168 Subjects Recruited In Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposis
Read original at benzingaBiodexa Pharmaceuticals shares are trading lower. The company announce that it has held its first round table meeting in Paris, France as part of expanding its support for Familial Adenomatous Polyposis patients and prescribers.
Read original at benzinga